InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Mack David Henry, Chief Executive Officer. Officer active across 1 companies, notably PMV Pharmaceuticals, Inc.. In total, 14 filings have been published. The latest transaction was filed on 27 April 2022 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations14 total
€16,57033,000 shares@ €0.50210.024% mcap26.2% of flow
Common Stock
SEC:0001209191-22-026341:0·
€25,21820,000 shares@ €1.26090.037% mcap39.8% of flow
Common Stock
SEC:0001209191-22-017591:0·
040,000 shares0
Common Stock
SEC:0001209191-21-070116·
040,000 shares0
Common Stock
SEC:0001209191-21-070116:0·
€2,4965,500 shares@ €0.45390.0036% mcap23.2% of flow
Common Stock
SEC:0001209191-21-052787·
€2,4965,500 shares@ €0.45390.0036% mcap3.9% of flow
Common Stock
SEC:0001209191-21-052787:0·
€4631,029 shares@ €0.44980.0007% mcap4.3% of flow
Common Stock
SEC:0001209191-21-047745·
€4631,029 shares@ €0.44980.0007% mcap0.7% of flow
Common Stock
SEC:0001209191-21-047745:0·
€91204 shares@ €0.44430.0001% mcap0.8% of flow
Common Stock
SEC:0001209191-21-043738·
€91204 shares@ €0.44430.0001% mcap0.1% of flow
Common Stock
SEC:0001209191-21-043738:0·
€4,33510,000 shares@ €0.43350.0063% mcap40.3% of flow
Common Stock
SEC:0001209191-21-038419·
€4,33510,000 shares@ €0.43350.0063% mcap6.8% of flow
Common Stock
SEC:0001209191-21-038419:0·
€3,3787,793 shares@ €0.43350.0049% mcap31.4% of flow
Common Stock
SEC:0001209191-21-035364·
€3,3787,793 shares@ €0.43350.0049% mcap5.3% of flow
Common Stock
SEC:0001209191-21-035364:0·
14 of 14 declarations
About Mack David Henry
David Henry Mack is President and Chief Executive Officer at PMV Pharmaceuticals, Inc., a biopharmaceutical company focused on developing innovative treatments. In his role, he leads the company's strategy and oversees operations to ensure its success. His leadership is essential for PMV in its mission to improve patients' lives.
